$Arcutis Biotherapeutics (ARQT.US)$ 短期股票持有人将遭受损失
已翻译
2
已翻译
2
$Arcutis Biotherapeutics (ARQT.US)$ 卖空者让它下跌,但这是一家强大的公司。鼓掌👏🏻👏🏻👏🏻
已翻译
2
Chris Koumentakos
赞并评论了
$Arcutis Biotherapeutics (ARQT.US)$
根据其良好的财报结果,我期望今天能有好表现。
根据其良好的财报结果,我期望今天能有好表现。
已翻译
4
3
$Arcutis Biotherapeutics (ARQT.US)$ 有人知道为什么这支股票被严重套现吗?
已翻译
4
$拍明芯城 (IZM.US)$ 或许有人知道我们不知道的事情。在34.89美元入场。
已翻译
1
$拍明芯城 (IZM.US)$ 7.270到52.210的惊人上升趋势,值得关注
已翻译
1
$九紫新能 (JZXN.US)$ 每个人都需要买入这波回调,下一个目标是10美元
已翻译
3
2
$Tempest Therapeutics (TPST.US)$
Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard of care
-
Reported new biomarker data in two important subpopulations, PD-L1 negative and b-catenin mutant patients, consistent with MoA of TPST-1120
-
Preparing to move TPST-1120 into a pivotal Phase 3 trial in HCC and TPST-1495 into a Phase 2 in FAP
Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard of care
-
Reported new biomarker data in two important subpopulations, PD-L1 negative and b-catenin mutant patients, consistent with MoA of TPST-1120
-
Preparing to move TPST-1120 into a pivotal Phase 3 trial in HCC and TPST-1495 into a Phase 2 in FAP
4